IBI363 + Chemotherapy
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer (NCT07325630) | Zhejiang Cancer Hospital | 2025-11-03 |
| Study of IBI363 in Patients with Advanced First-line Gastric Cancer (NCT06610799) | Xiangdong Cheng | 2024-10-15 |
Track IBI363 + Chemotherapy automatically
Every clearance here is in the API, with alerts when new ones post.